MYO-TRU is a comprehensive PCOS-focused nutritional sachet designed around the complementary roles of Myo-Inositol, D-Chiro Inositol, folate, Vitamin D, Vitamin B6, B12 and Chromium. It is positioned to support metabolic balance, reproductive wellness and nutritional adequacy in women, particularly within lifestyle-oriented PCOS care. Its single-sachet format improves convenience, making it a strong PCD Pharma Gynae, PCOS & Nutritional Support offering.
It is positioned for nutritional and metabolic support in women, particularly in PCOS-focused wellness programs.
No, PCOS requires individualized lifestyle and medical management.
It may provide nutritional support as part of a broader management plan.
Only after professional advice.
Use consistently according to the recommended serving and combine supplementation with balanced nutrition, regular exercise, adequate sleep and healthy weight management where appropriate. Women taking glucose-lowering medicines or undergoing fertility treatment should discuss supplementation with their physician. Avoid unnecessary duplication with other folate, Vitamin D or inositol products unless specifically recommended.
The formulation is generally well tolerated, although nausea, abdominal discomfort, bloating, loose stools or headache can occasionally occur. Chromium and other micronutrients may affect individuals differently depending on baseline nutritional status and concurrent supplementation. People receiving diabetes medication should be mindful of overall glucose management. Persistent menstrual irregularity, infertility symptoms or significant metabolic concerns require clinical evaluation rather than exclusive reliance on nutritional supplementation.
MYO-TRU: Myo-Inositol and D-Chiro Inositol are involved in insulin-signalling pathways and are widely studied in relation to metabolic and reproductive health, particularly in women with PCOS. Folic Acid, Vitamin D3 and Vitamin B12 provide complementary nutritional support, while Vitamin B6 contributes to normal metabolism and Chromium participates in glucose-related metabolic processes. The formulation therefore supports a broader nutritional and metabolic approach rather than a single-drug mechanism.